Intramucosal acidosis and systemic host responses in abdominal aortic aneurysm surgery

Critical Care Medicine

Volumn 25, Issue 9, 1997, Pages 1472-1479

  Soong, Chee V ^a   Halliday, M Isla ^b   Barclay, G Robin ^c   Hood, John M ^a   Rowlands, Brian J ^b   Barros D'Sa, Aires A B ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c Edinburgh Regional Transfusion Centre   (United Kingdom)

Author keywords

Aortic aneurysm repair surgery; Endotoxin; Endotoxin antibodies; Multiple organ dysfunction syndrome; Soluble p55TNF receptor; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; ENDOTOXIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR;

ABDOMINAL AORTA ANEURYSM; ADULT; ANESTHESIA INDUCTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; HUMAN; IMMUNE RESPONSE; INTESTINE ISCHEMIA; PATHOGENESIS; PH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECEPTOR BINDING; RETROSPECTIVE STUDY; SIGMOID; TONOMETRY;

EID: 0030866031     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199709000-00013     Document Type: Article

References (49)

1. Soreide O, Grimsgaard CHR, Myhre HO, et al: Time and cause of death for 301 patients operated on for abdominal aortic aneurysm. Age Ageing 1982; 11: 256-260
2. Campbell WB, Collin J, Morris PS: The mortality of abdominal aortic aneurysm. Ann R Coll Surg Engl 1986; 68:275-278
3. Bone RC, Sprung CL, Sibbald WJ: Definitions for sepsis and organ failure. Crit Care Med 1992; 20:724-725
4. Knaus WA, Draper EA, Wagner DP, et al: Prognosis in acute organ-system failure. Ann Surg 1985; 202:685-693
5. Fiddian-Green RG, Gantz NM: Transient episodes of sigmoid ischemia and their relation to infection from intestinal organisms after abdominal aortic operations. Crit Care Med 1987; 15: 835-839
6. Soong CV, Blair PHB, Halliday MI, et al: Endotoxaemia, the generation of cytokines and their relationship to intramucosal acidosis of the sigmoid colon in elective abdominal aortic aneurysm repair. Eur J Vasc Surg 1993; 7:534-539
7. Soong CV, Blair PHB, Halliday MI, et al: Bowel ischaemia and organ impairment in elective abdominal aortic aneurysm repair. Br J Surg 1994; 81:965-968
8. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-1486
9. Marks JD, Marks CB, Luce JM, et al: Plasma tumor necrosis factor in patients with septic shock Am Rev Respir Dis 1990; 141:94-97
10. Danner RL, Elin RJ, Hossein JM, et al: Endotoxemia in human septic shock. Chest 1991; 99:169-175
11. Fink PC, Lehr L, Urbascheck RM, et al: Limulus amoebocyte lysate test for endotoxaemia investigations with a femtogram sensitive spectrophotometric assay. Clin Worchenschir 1981; 59: 213-218
12. Caridis DT, Reinhold RB, Woodruff PWH, et al: Endotoxaemia in man. Lancet 1972; ii:1381-1386
13. Watson RWG, Redmond HP, McCarthy J, et al: Endotoxin regulates early host response to surgery. Br J Surg 1994; 81: 757
14. Blick M, Sherwin SA, Rosenbaum M, et al: Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987; 47:2986-2989
15. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1418-1446
16. McCrory D, Weir C, Halliday et al: The reliability of endotoxin and cytokine measurements in polytrauma patients and their relationship to the development of sepsis. Intensive Care Med 1994; 20:461
17. Bayston KF, Cohen J: Bacterial endotoxin and current concepts in the diagnosis and treatment of endotoxaemia. J Med Microbiol 1990; 31:73-83
18. Westphal O, Jann K, Himmelspach K: Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Progress in Allergy 1983; 33:9-39
19. Barclay GR, Scott BB, Wright IH, et al: Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of Gram-negative septic shock. Circ Shock 1989; 29:93-106
20. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869-871
21. Hohmann H-P, Remy R, Brockhaus M, et al: Two different cell types have different major receptors for human tumor necrosis factor (TNFα). J Biol Chem 1989; 264:14927-14934
22. Aderka D, Wysenbeek A, Engelmann H, et al: Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993; 36:1111-1120
23. Barrera P, Boerbooms AM, Jansson EM, et al: Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 1993; 36: 1070-1079
24. Tan LR, Waxman K, Scannell G, et al: Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma 1993; 34:634-638
25. Spinas GA, Keller U, Brockhaus M: Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxemia. J Clin Invest 1992; 90: 533-536
26. Aderka D, Engelmann H, Ma ORY, et al: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175:323-329
27. 2 mixtures. J Clin Invest 1964; 43: 193-200
28. Fiddian-Green RG, Amelin PM, Herrmann JB, et al: Prediction of the development of sigmoid ischemia on the day of aortic operations. Arch Surg 1986; 121:654-660
29. Grum CM, Fiddian-Green RG, Pittenger GL, et al: Adequacy of tissue oxygenation in intact dog intestine. Am J Physiol 1984; 56:1065-1069
30. Fink MP, Cohn SM, Lee PC, et al: Effect of lipopolysaccharide on intestinal intramucosal hydrogen ion concentration in pigs: Evidence of gut ischemia in normodynamic model of septic shock. Crit Care Med 1989; 17:641-646
31. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease clarification system. Crit Care Med 1985; 13:818-829
32. Barclay GR, Scott BB: Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies. Infect Immun 1987; 55:2706-1714
33. Leen CLS, Barclay GR, McClelland DBL, et al: Double-blind comparative trial of standard (commercial) and antibody-affinity purified toxoid vaccines. J Infect 1987; 14:119-124
34. Paterson IS, Klausner JM, Goldman G, et al: Pulmonary edema after aneurysm surgery is modified by mannitol. Ann Surg 1989; 210:796-801
35. Poggetti RS, Moore EA, Moore EE, et al: Simultaneous liver and lung injury following gut ischemia is mediated by xanthine oxidase. J Trauma 1992; 32: 723-728
36. Baigrie RJ, Lamont PM, Kwiatkowski D, et al: Systemic cytokine response after major surgery. Br J Surg 1992; 79:757-760
37. Freeman R, Gould FK: Prevention of fever and Gram-negative infection after open heart surgery by anti endotoxin. Thorax 1985; 40:846-848
38. Wessels BC, Wells MT, Gaffin SL, et al: Plasma endotoxin concentration in healthy primates and during E. coli-induced shock. Crit Care Med 1988; 16:601-605
39. Nys M, Joassin L, Somzee A, et al: Enzyme-linked immunosorbent assay for immunoglobulin G subclass antibodies specific for enterobacterial recore glycolipid in healthy individuals and in patients infected by Gram-negative bacteria. J Clin Microbiol 1988; 26: 857-862
40. Brauner A, Svenson SB, Wretlind B: Antibody responses to lipid A and core oligosaccharides in patients with bacteraemia. Serodiagnosis and Immunotherapy in Infectious Disease 1987; 1: 431-440
41. Mythen MG, Barclay GR, Purdy G, et al: The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of postoperative organ dysfunction. Blood Coagul Fibrinolysis 1993; 4:999-1005
42. Debets JMH, Kampmeijer R, van der Linden MPMH, et al: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989; 17:489-494
43. Gold'ie AS, Fearon KCH, Ross JA, et al: Natural cytokine antagonists and endotoxin anti-endotoxin core antibodies in sepsis syndrome. JAMA 1995; 274: 172-177
44. Chouaib S, Brannellec D, Buurman WA: More insights into the complex physiology of TNF. Immunol Today 1991; 12: 141-142
45. Aderka D, Engelmann H, Shemer-Avni Y, et al: Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 1992; 11:157-159
46. Gardiner KR, Halliday MI, Barclay GR, et al: The significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995; 36:897-901
47. Barath P, Fishbein MC, Cao J, et al: Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65:297-302
48. Van Zee KJ, Kohno T, Fischer E, et al: TNF soluble receptors circulate during experimental and clinical inflammation and can protect against excessive TNF in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89:4845-4890
49. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24:1125-1128